期刊文献+

载脂蛋白C-Ⅲ研究进展 被引量:8

Advances in Research into Apolipoprotein C-Ⅲ
下载PDF
导出
摘要 载脂蛋白C-Ⅲ是一种水溶性低分子蛋白质,主要分布于血浆高密度脂蛋白、极低密度脂蛋白和乳糜微粒中。新近研究表明,载脂蛋白C-Ⅲ是脂蛋白代谢的重要调节因子,与高三酰甘油血症和心血管疾病进展相关联。载脂蛋白C-Ⅲ在代谢综合征和动脉粥样硬化中起重要作用,可能是心血管疾病进展的重要预测因子。调节载脂蛋白C-Ⅲ代谢也许是控制代谢综合征患者血脂代谢异常和治疗心血管疾病发病的一重要靶点。 Apolipoprotein C-Ⅲ(apoC-Ⅲ),a soluble low molecular protein,mainly found among plasma high-density lipoprotein,very low-density lipoprotein and chylomicron.Recent studies have demonstrated that apoC-Ⅲ is an important regulator of lipoprotein metabolism,and is strongly associated with hypertriglyceridaemia,and the progression of cardiovascular disease(CVD).apoC-Ⅲ plays a significant role in both metabolic syndrome,and atherosclerosis.Elevated apoC-Ⅲ is an important predictor of the progression of CVD.Regulating apoC-Ⅲ metabolism may be a significant new therapeutic target for managing dyslipidaemia and CVD risk in metabolic syndrome.
出处 《心血管病学进展》 CAS 2009年第5期798-801,共4页 Advances in Cardiovascular Diseases
基金 国家自然科学基金(30570958) 国家博士后科学基金资助金(20060400953) 江苏省"135工程"开放课题资助项目资助
关键词 载脂蛋白C-Ⅲ 心血管疾病 血脂代谢异常 高三酰甘油血症 代谢综合征 预测因子 apolipoprotein C-Ⅲ cardiovascular disease dyslipidaemia hypertriglyceridaemia metabolic syndrome predictor
  • 相关文献

参考文献26

  • 1Wang CS,McConathy WJ,Kloer HU,et al.Modulation of lipoprotein lipase activity by apolipoproteins.Effect of apolipoprotein C-Ⅲ[J].J Clin Invest,1985,75:384-390.
  • 2McConathy WJ,Gesquiere JC,Bass H,et al.Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-Ⅲ[J].Lipid Res,1992,33(7):995-1003.
  • 3Grundy SM.Atlas of Atherosclerosis:Risk Factors and Treatment,Current Medicine[M].Philadelphia,PA:Current Medicine,LLC,2005.
  • 4Schaap FG,Nierman MC,Berbée JF,et al.Evidence for a complex relationship between apoA-V and apoC-Ⅲ in patients with severe hypertriglyceridemia[J].J Lipid Res,2006,47:2333-2339.
  • 5Chan DC,Watts GF,Nguyen MN,et al.Apolipoproteins C-Ⅲ and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics[J].Arterioscler Thromb Vasc Biol,2006,26:590-596.
  • 6Gerritsen G,Rensen PC,Kypreos KE,et al.ApoC-Ⅲ deficiency prevents hyperlipidemia induced by apoE overexpression[J].Lipid Res,2005,46:1466-1473.
  • 7von Eckardstein A,Holz H,Sandkamp M,et al.ApolipoproteinC-Ⅲ(Lys58→Glu).Identification of an apolipoprotein C-Ⅲ variant in a family with hyperαlipoproteinemia[J].J Clin Invest,1991,87:1724-1731.
  • 8Chan DC,Watts GF,Barrett PHR,et al.Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity[J].Clin Chem,2002,48:278-283.
  • 9Nguyen MN,Chan DC,Dwyer KP,et al.Use of intralipid for kinetic analysis of HDL apoC-Ⅲ:evidence for a homogeneous kinetic pool of apoC-Ⅲ in plasma[J].Lipid Res,2006,47:1274-1280.
  • 10Takahashi T,Hirano T,Okada K,et al.Apolipoprotein CⅢ deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice[J].Metab Clin Exp,2003,52:1354-1359.

同被引文献93

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部